NIRAJA DALAL: Open Payments
NPI 1386194132 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 43 payments from 11 companies in 2025. Trend: 2023 $47 · 2024 $38 · 2025 $1,149
Food & beverage: $1,149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $606 |
| Lilly USA, LLC | 9 | $218 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| GENZYME CORPORATION | 3 | $50 |
| Novo Nordisk Inc | 2 | $44 |
| Ardelyx, Inc. | 2 | $35 |
| QOL Medical, LLC | 1 | $23 |
| Celltrion USA Inc. | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
Products named: SKYRIZI, RINVOQ, ZEPBOUND, OMVOH, XIFAXAN, ENTYVIO, DUPIXENT, Wegovy.
Industry payments across OH — which companies pay providers there.
